Bacillus Clausii Multi ATB Resist + Placebo
ApprovedCompleted 0 watching 0 views this week🔥 Hot
84
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Diarrhea, Infantile
Conditions
Diarrhea, Infantile
Trial Timeline
Jul 1, 2006 → —
NCT ID
NCT00447161About Bacillus Clausii Multi ATB Resist + Placebo
Bacillus Clausii Multi ATB Resist + Placebo is a approved stage product being developed by Sanofi for Diarrhea, Infantile. The current trial status is completed. This product is registered under clinical trial identifier NCT00447161. Target conditions include Diarrhea, Infantile.
Hype Score Breakdown
Clinical
30
Activity
20
Company
9
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00447161 | Approved | Completed |
Competing Products
20 competing products in Diarrhea, Infantile